Literature DB >> 21489578

Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study.

Christina Voulgari1, Nicholas Katsilambros, Nicholas Tentolouris.   

Abstract

The objective of the study was to assess the effect of smoking cessation on microalbuminuria in subjects with newly diagnosed type 2 diabetes mellitus (DM). From 500 smokers newly diagnosed with type 2 DM and microalbuminuria, only 193 (96 men/97 women; age, 56.4 ± 7.8 years) agreed to participate and were educated on smoking cessation, diet, and exercise. Pharmacological interventions were not different among the studied groups. All subjects were contacted by phone monthly with emphasis on smoking cessation. Anthropometric, biochemical parameters and urine specimens were obtained at baseline and at 12-month follow-up. Microalbuminuria was defined as an albumin to creatinine ratio of 30 to 299.9 μg/mg creatinine. Ankle brachial pressure index was determined by ultrasound. A total of 120 (62.2%) subjects quit smoking. Prevalence of microalbuminuria was reduced at 1 year to 72.6% in the subjects who quit smoking and to 22.5% in those who continued smoking (P = .015). Multivariate logistic regression analysis demonstrated that independently associated with the reduction in albumin to creatinine ratio (84.8 vs 28.7 μg/mg creatinine) were amelioration of glycemic control (P < .001), blood pressure (P = .02), dyslipidemia (P = .02), and insulin resistance (P = .05). Smoking cessation also reduced the prevalence of peripheral vascular disease (P = .03) and neuropathy (P = .04). From the pharmacological and lifestyle interventions, smoking cessation had the highest and an independent contribution to the reduction of microalbuminuria (P < .001). Smoking cessation in newly diagnosed type 2 DM patients is associated with amelioration of metabolic parameters, blood pressure, and the reduction of microalbuminuria. Stricter counseling about the importance of quitting smoking upon type 2 DM diagnosis is necessary to protect against the development of diabetic nephropathy and vascular complications.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21489578     DOI: 10.1016/j.metabol.2011.02.014

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

Review 1.  Smoking as a risk factor for diabetic nephropathy: a meta-analysis.

Authors:  Sensen Su; Wanning Wang; Tao Sun; Fuzhe Ma; Yue Wang; Jia Li; Zhonggao Xu
Journal:  Int Urol Nephrol       Date:  2017-06-19       Impact factor: 2.370

2.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

Review 3.  Metabolic effects of smoking cessation.

Authors:  Kindred K Harris; Mohan Zopey; Theodore C Friedman
Journal:  Nat Rev Endocrinol       Date:  2016-03-04       Impact factor: 43.330

Review 4.  The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.

Authors:  Carole Clair; Marya J Cohen; Florian Eichler; Kevin J Selby; Nancy A Rigotti
Journal:  J Gen Intern Med       Date:  2015-05-07       Impact factor: 5.128

Review 5.  Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review.

Authors:  Magdalena Walicka; Cristina Russo; Michael Baxter; Isaac John; Grazia Caci; Riccardo Polosa
Journal:  World J Diabetes       Date:  2022-06-15

6.  Does smoking increase the risk of progression of nephropathy and/or cardiovascular disease in type 2 diabetic patients with albuminuria and those without albuminuria?

Authors:  Yassamine Bentata; Ilham Karimi; Nawal Benabdellah; Fatiha El Alaoui; Intissar Haddiya; Redouane Abouqal
Journal:  Am J Cardiovasc Dis       Date:  2016-05-18

7.  Association of tobacco products use and diabetes mellitus-results of a national survey among adults in saudi arabia.

Authors:  Abdalla Abdelwahid Saeed
Journal:  Balkan Med J       Date:  2012-09-01       Impact factor: 2.021

Review 8.  Lifestyle Modification for Secondary Stroke Prevention.

Authors:  Ryan R Bailey
Journal:  Am J Lifestyle Med       Date:  2016-02-21

9.  Effectiveness of a Multicomponent Intervention in Primary Care That Addresses Patients with Diabetes Mellitus with Two or More Unhealthy Habits, Such as Diet, Physical Activity or Smoking: Multicenter Randomized Cluster Trial (EIRA Study).

Authors:  Francisco Represas-Carrera; Sabela Couso-Viana; Fátima Méndez-López; Bárbara Masluk; Rosa Magallón-Botaya; Jose I Recio-Rodríguez; Haizea Pombo; Alfonso Leiva-Rus; Montserrat Gil-Girbau; Emma Motrico; Ruth Martí-Lluch; Francisco Gude; Ana Clavería
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 3.390

Review 10.  Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy.

Authors:  Christian Mende
Journal:  Adv Ther       Date:  2015-12-09       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.